¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Breast development, early"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • breast reconstruction
    À¯¹æÀç°Ç(¼ú), Á¥Àç°Ç(¼ú)
  • breast reduction
    À¯¹æÁÙÀÓ(¼ú), À¯¹æÃà¼Ò(¼ú)
  • breast-feeding
    ¸ðÀ¯¼öÀ¯, Á¥¸ÔÀÓ
  • caked breast
    ÄÉÀÌÅ©À¯¹æ
  • funnel breast
    ¿À¸ñ°¡½¿, ´©µÎÈä
  • giant breast
    °Å´ëÀ¯¹æ
  • irritable breast
    °ú¹ÎÀ¯¹æ
  • male breast
    ³²¼ºÀ¯¹æ
  • occult breast carcinoma
    ÀáÀçÀ¯¹æ¾ÏÁ¾
  • pigeon breast
    »õ°¡½¿
  • pigeon breast deformity
    ºñµÑ±â°¡½¿º¯Çü
  • self-breast examination
    ÀÚ°¡À¯¹æ°ËÁø(¹ý)
  • silicone-gel breast implant
    ½Ç¸®ÄܰÖÀ¯¹æ»ðÀÔ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • communicative development
    ÀÇ»ç¼ÒÅë¹ß´Þ
  • community development
    Áö¿ª»çȸ°³¹ß
  • curriculum development
    ±³À°°úÁ¤ÀÛ¼º, ±³À°°úÁ¤°³¹ß
  • development
    ¹ß´Þ, ¹ß»ý, ¹ßÀ°
  • development quotient
    ¹ß´ÞÁö¼ö
  • digenetic development
    º¹¼¼´ë¹ßÀ°
  • direct development
    Á÷Á¢¹ßÀ°
  • ego development
    ÀھƹߴÞ
  • emotional development
    °¨Á¤¹ß´Þ
  • heterogonic development
    °£Á¢¹ßÀ°
  • homogonic development
    Á÷Á¢¹ßÀ°
  • mental development
    Áö´É¹ß´Þ
  • moral development
    µµ´ö¹ß´Þ
  • motor development
    ¿îµ¿¹ß´Þ
  • personality development
    ÀΰݹߴÞ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • self-help, development
    ÀÚÁ¶(¹ß´Þ¿¡¼­)
  • sensory development
    °¨°¢<Áö°¢>¹ß´Þ (¡­Û¡Ó¹).
  • sexual development
    ¼º¹ß´Þ
  • various kind of obstacles of development
    °¢Á¾¼ºÀåÀå¾Ö(¡­î¡äô).
  • various kind of obstacles of development
    °¢Á¾¼ºÀåÀå¾Ö(¡­î¡äô)
  • amblyopia of early arrest
    Á¶±âÁ¤Áö¾à½Ã
  • early
    Á¶±â
  • early ambulation
    Á¶±â¿îµ¿½ÃÀÛ.
  • early ambulation
    Á¶±â¿îµ¿
  • early antigen
    ÃʱâÃâÇöÇ׿ø
  • early antigen
    Á¶±â Ç׿ø
  • early antigen
    ÃʱâÇ׿ø
  • early cancer
    Á¶±â¾Ï(ðÄÑ¢äß).
  • early cancer
    Á¶±â¾Ï(Á¶±â¾Ï).
  • early delivery
    Á¶±âºÐ¸¸.
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
BCEI breast cancer estrogen-inducible
BCF basophil chemotactic factor; bioconcentration factor; breast cyst fluid
BCFP breast cyst fluid protein
BCPT breast cancer prevention trial
BCQ breast cancer questionnaire
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
NICHD National Institute of Child Health and Human Development
NDU Nursing Development Unit
OECD Organisation for Economic Co-operation and Development
PEG-rHuMGDF PEGylated recombinant human megakaryocyte growth and development factor
PDI Psychomotor Development Index
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • early childhood
    Ãʱ⠾Ƶ¿±â
    ¸¸ 1-6¼¼ ±îÁöÀÇ ½Ã±â.
  • early clinical symptom
    Ãʱâ ÀÓ»ó Áõ»ó
  • early closing clicking joint noise
    Æó±¸ ÃʱâÀÇ ´Ü¼ø °üÀýÀâÀ½
    ÇÏ¾Ç °úµÎÀÇ ÈĹæ ȰÁÖ ¿îµ¿ Ãʱ⿡ ¹ß»ýÇÏ´Â °üÀýÀ½.
  • early diagnosis
    Á¶±â Áø´Ü
    º´ÀÇ ÁøÇà¿¡ ¾Õ¼­ Áø´ÜÇÏ¿© ´ëÃ¥À» ¼¼¿ò, ¿ÏÀü Ä¡À¯ ±â´ë.
  • early distal tubule
    Ãʱ⠿øÀ§ ¼¼´¢°ü
  • early gestation
    ÀӽŠÃʱâ
  • early melanoma
    Ãʱâ Èæ»öÁ¾
    ¸á¶ó´Ñ ¼¼Æ÷ÀÇ ¾Ç¼º Á¾¾ç¿¡ Ãʱ⠴ܰè. Á¾Á¾ ¾ç¼º ¸ð¹ÝÀ¸·Î ¿ÀÇØµÈ´Ù. ±¸°­¿¡¼­ °¡Àå ÈçÇÑ Èæ»öÁ¾Àº Ç¥Ãþ È®À强 Èæ»öÁ¾, °áÀý¼º Èæ»öÁ¾, ¸»´ÜÈæ»öÁ¾À¸·Î ³ª´µ¾îÁø´Ù. ¿¹Èİ¡ ³ª»Ú´Ù.
  • early nodular melanoma
    Ãʱ⠼ҰáÀý¼º Èæ»öÁ¾
  • early opening clicking joint noise
    °³±¸ ÃʱâÀÇ ´Ü¼ø °üÀýÀâÀ½
    ÇÏ¾Ç °úµÎÀÇ Àü¹æ ȰÁֿ Ãʱ⿡ ¹ß»ýÇÏ´Â °üÀýÀ½.
  • early petechiae
    Ãʱâ Á¡»ó ÃâÇ÷
  • early postprandial postgastrectomy syndrome
    Á¶±â ½ÄÈļº À§ ÀýÁ¦ ÈÄ ÁõÈıº
  • early primary closure
    Á¶±â 1Â÷ ºÀÇÕ
  • early sharp pain
    ÃʱâÀÇ ¿¹¸®ÇÑ ÅëÁõ, ÃʱâÀÇ ¿¹¸®ÇÑ µ¿Åë
    Á¶Á÷ÀÇ ¼Õ»ó ½Ã¿¡ ¿©·¯ ½Å°æ¼¶À¯Áß A¥ä¼¶À¯°¡ ¸ÕÀú ½Å°æÀü´ÞÀ» ÇàÇϴµ¥ ÀÌ´Â ºü¸£°í ³¯Ä«·Î¿î ÅëÁõÀ» º¸ÀδÙ. ÀÌÈÄ¿¡ ´À¸®°í ¹¬Á÷ÇÑ ÅëÁõÀÌ ¿À´Â C ¼¶À¯°¡ Àü´ÞÀ» ÇàÇÑ´Ù.
  • early symptom
    Ãʱâ Áõ»ó
  • early treatment
    Á¶±â Ä¡·á
    Ä¡·á È¿°ú¸¦ ¿Ã¸®±â ½¬¿î ½Ã±â¿¡ Ä¡·á¸¦ ÇàÇÏ´Â °Í.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
growth and embryonic development Developmental processes from cell division to embryogenesis to postnatal growth and maturity.
(12 Dec 1998)
pervasive development disorder <neurology, psychiatry> A large group of developmental disabilities which are neurological disorders, usually of unknown cause.
Characteristics include reduced abilities to understand language and communicate normally, reduced ability to socially interact with others in a normal manner, and limited variety in activities and interests. Individuals will also often respond in unusual ways to sensations, engage in repetitive activities, and resist changes to the environment or to daily routines.
Types of pervasive development disorder include autism, Retts Syndrome, Hellers Syndrome, and Aspergers Syndrome.
Acronym: PDD
(12 Jan 1998)
consensus development conference Designation for summary statements representing the majority and current agreement of physicians, scientists, and other professionals meeting to reach a consensus on a selected subject.
(12 Dec 1998)
consensus development conferences Presentations of summary statements representing the majority agreement of physicians, scientists, and other professionals convening for the purpose of reaching a consensus--often with findings and recommendations--on a subject of interest. The conference, consisting of participants representing the scientific and lay viewpoints, is a significant means of evaluating current medical thought and reflects the latest advances in research for the respective field being addressed.
(12 Dec 1998)
consensus development conferences, nih Articles on conferences sponsored by nih presenting summary statements representing the majority agreement of physicians, scientists, and other professionals convening for the purpose of reaching a consensus on a subject of interest. This heading is used for nih consensus conferences as a means of scientific communication. In indexing it is viewed as a type of review article and as a tag for any article appearing in any publication of the nih office of medical applications of research (omar).
(12 Dec 1998)
program development The process of formulating, improving, and expanding educational, managerial, or service-oriented work plans (excluding computer program development).
(12 Dec 1998)
psychosexual development The stages of development of the psychological aspects of sexuality from birth to adulthood; i.e., oral, anal, genital, and latent periods.
(12 Dec 1998)
human development Continuous sequential changes which occur in the physiological and psychological functions during the individual's life.
(12 Dec 1998)
staff development The process by which the employer promotes staff performance and efficiency consistent with management goals and objectives.
(12 Dec 1998)
state health planning and development agencies Agencies established under pl93-641 to coordinate, conduct, and implement state health planning activities. Two primary responsibilities are the preparation of an annual state health plan and giving assistance to the statewide health coordinating council.
(12 Dec 1998)
strain development Improving the genetics of an organism so that it carries out a biotechnological process more effectively.
(14 Nov 1997)
development 1. The act of developing or disclosing that which is unknown; a gradual unfolding process by which anything is developed, as a plan or method, or an image upon a photographic plate; gradual advancement or growth through a series of progressive changes; also, the result of developing, or a developed state. "A new development of imagination, taste, and poetry." (Channing)
2. <biology> The series of changes which animal and vegetable organisms undergo in their passage from the embryonic state to maturity, from a lower to a higher state of organization.
3. <mathematics> The act or process of changing or expanding an expression into another of equivalent value or meaning. The equivalent expression into which another has been developed.
4. The elaboration of a theme or subject; the unfolding of a musical idea; the evolution of a whole piece or movement from a leading theme or motive.
<biology> Development theory, the doctrine that animals and plants possess the power of passing by slow and successive stages from a lower to a higher state of organization, and that all the higher forms of life now in existence were thus developed by uniform laws from lower forms, and are not the result of special creative acts. See the Note under Darwinian.
Synonym: Unfolding, disclosure, unraveling, evolution, elaboration, growth.
Origin: Cf. F. Developpement
Alternative forms: developement.
Source: Websters Dictionary
(01 Mar 1998)
drug development pathway The various procedures and studies that must be undertaken to satisfy Food and Drug Administration requirements for drug approval and marketing.
(14 Nov 1997)
foetal development Morphologic and physiologic growth and development of the mammalian embryo or foetus.
(12 Dec 1998)
land conservation and development commission (LCDC) A commission appointed to determine land use policy in Oregon.
(05 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Early Modern English
    ÃÊ±â ±Ù´ë ¿µ¾î
  • early
    À̸¥;ÃʱâÀÇ;ÀϵǴÂ;¸º¹°ÀÇ;¾î¸±¶§ÀÇ;°¡±î¿î Àå·¡ÀÇ(at an early date)±Ý¸í°£¿¡;¸ÓÁö ¾Ê¾Æ;ÀÏÂïÀÚ°í ÀÏÂï ÀϾ´Ù(keep early hours);ÀÏÂï;À̸¥ ¶§¿¡;Ãʱ⿡
  • early Victorian
    ºòÅ丮¾Æ ¿ÕÁ¶ ÃʱâÀÇ(»ç¶÷(ÀÛ°¡));±¸½ÄÀÇ(»ç¶÷)
  • early bird
    (±¸)À̸¥ ¾ÆÄ§ÀÇ;ÀÏÂï ¿À´Â »ç¶÷À» À§ÇÑ
  • early bird
    ÀÏÂï ÀϾ´Â »ç¶÷;Á¤ÇÑ ½Ã°¢º¸´Ù ÀÏÂï ¿À´Â »ç¶÷
  • early closing
    °³Á¡ ½Ã°£ ´ÜÃà(ÀÏ)
  • early door
    Ưº° ÃâÀÔ±¸(Ưº° ¿ä±ÝÀ¸·Î Á¤°¢º¸´Ù »¡¸® ÀÔÀå½ÃŰ´Â ¹®)
  • early leaver
    (¿µ)(Çб³ÀÇ)Áßµµ ÅðÇÐÀÚ;³«¿ÀÀÚ
  • early warning
    (¹æ°ø µîÀÇ)Á¶±â °æº¸
  • early-to-bedder
    ÀÏÂï ÀÚ´Â »ç¶÷
  • early-warning radar
    ÇÙ°ø°Ý¿¡ ´ëÇÑ Á¶±â °æº¸ ·¹ÀÌ´õ
  • early-warning system
    (±º)(ÇÙ°ø°Ý¿¡ ´ëÇÑ)Á¶±â °æº¸ Á¶Á÷
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á